The U.S. and Europe cleanrooms market size is expected to reach USD 7.93 billion by 2030, registering a CAGR of 2.7% from 2023 to 2030. Growing presence of stringent regulations for sterile compounding of hazardous drugs and increasing incidence of Hospital-acquired Infections (HAIs) are among key factors driving the market. In addition, technological advancements in cleanrooms are expected to contribute toward market growth.
Rising incidence of HAIs is one of the key factors driving demand for cleanrooms in hospitals. According to data published by the National Institute for Health and Care Excellence, in England, about 300, 000 patients contract HAIs each year as a result of care within the National Health Service. Likewise, as per CDC, there were about 722, 000 reported cases of HAIs in the U.S.
The penetration of cleanrooms in compounding pharmacies is high in the U.S. due to presence of government regulations such as USP 797 and USP 800. As per the Pharmacy Purchasing and Products report (2016), compounding sites reported a 73% compliance with USP 797 standards and about 48% compounding sites were compliant with the newly proposed USP 800 standards. Thus, stringent regulations for drug compounding contribute toward market growth.
This product will be delivered within 1-3 business days.
Rising incidence of HAIs is one of the key factors driving demand for cleanrooms in hospitals. According to data published by the National Institute for Health and Care Excellence, in England, about 300, 000 patients contract HAIs each year as a result of care within the National Health Service. Likewise, as per CDC, there were about 722, 000 reported cases of HAIs in the U.S.
The penetration of cleanrooms in compounding pharmacies is high in the U.S. due to presence of government regulations such as USP 797 and USP 800. As per the Pharmacy Purchasing and Products report (2016), compounding sites reported a 73% compliance with USP 797 standards and about 48% compounding sites were compliant with the newly proposed USP 800 standards. Thus, stringent regulations for drug compounding contribute toward market growth.
U.S. And Europe Cleanrooms Market Report Highlights
- Compounding pharmacies held the largest revenue share of nearly 92.9% in 2022. This can be attributed to presence of stringent regulations for drug compounding, which has increased the penetration of cleanrooms in compounding pharmacies
- U.S. held the largest revenue share owing to stringent government regulations for drug compounding and presence of well-established healthcare infrastructure
- Europe is expected to emerge with the fastest CAGR over the forecast period owing to rise in the incidence of HIAs, favorable government initiatives toward infection control, and improvements in healthcare infrastructure
- Key players include in U.S. and Europe cleanrooms market are Mecart, Clean Air Products, Terra Universal, and Nicomac Srl, among others.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. and Europe Cleanrooms Market Variables, Trends & Scope
Chapter 4. U.S. and Europe Cleanrooms: Europe Estimates & Trend Analysis
Chapter 5. U.S. and Europe Cleanrooms Market: Regional Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- ISOLTECH Srl
- ALLIED CLEANROOMS
- Angstrom Technology
- Nicomac Srl
- Terra Universal, Inc.
- MECART
- Clean Room Depot
- Clean Air Products
- Asgatech Holding Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 66 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 6.37 Billion |
| Forecasted Market Value ( USD | $ 7.93 Billion |
| Compound Annual Growth Rate | 2.7% |
| Regions Covered | Europe, United States |
| No. of Companies Mentioned | 9 |
